Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 121M 106M 97.64M 91.41M 171M 175M 1.17B 454M 5.63B 454M 444M 19.53B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 75.59M 66.28M 61.1M 57.2M 107M 109M 734M 284M 3.52B 284M 278M 12.22B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.56%
Yield 2024 *
-
Yield 2025 -
1 day+0.93%
1 week+7.35%
Current month+33.30%
1 month+33.30%
3 months+54.28%
6 months+126.23%
Current year+130.03%
1 week 189.31
Extreme 189.31
211
1 month 152.8
Extreme 152.8
211
Current year 87.25
Extreme 87.25
211
1 year 87.15
Extreme 87.15
211
3 years 68.72
Extreme 68.72
211
5 years 52.65
Extreme 52.65
211
10 years 15
Extreme 15
211
Manager TitleAgeSince
Chief Executive Officer 74 1995-01-03
Chief Executive Officer 43 2011-06-14
Director of Finance/CFO - 2018-09-28
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 2010-03-22
Date Insider Type Main position Quantity % Market Cap.
24-09-11Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+7.35%+81.45%+135.51% 185M
+1.08%+1.15%+12.45%+79.19% 47.38B
+0.79%+2.83%+52.57%+106.39% 35.48B
+2.77%+4.52%-1.74%+45.79% 12.33B
+1.23%+2.87%+12.80%+91.53% 11.65B
-1.52%+0.38%+36.72%+126.29% 8.88B
+0.99%+4.52%+21.27%+44.41% 7.21B
+1.37%+2.75%+54.59%-8.50% 6.91B
+1.30%-0.35%+24.55%+223.12% 6.45B
-3.83%-0.76%-35.52%-3.58% 4.94B
Average +0.54%+4.27%+25.91%+84.01% 14.14B
Weighted average by Cap. +0.89%+2.88%+24.31%+84.76%

Financials

2024 2025
Net sales 12.97B 138M 121M 111M 104M 195M 199M 1.34B 517M 6.41B 516M 505M 22.23B 5.62B 59.55M 52.21M 48.13M 45.06M 84.49M 86.24M 578M 224M 2.78B 224M 219M 9.63B
Net income 4.21B 44.63M 39.13M 36.07M 33.77M 63.32M 64.63M 433M 168M 2.08B 168M 164M 7.21B 2.5B 26.55M 23.28M 21.46M 20.09M 37.67M 38.46M 258M 99.81M 1.24B 99.7M 97.53M 4.29B
Net Debt -4.15B -44.03M -38.6M -35.58M -33.31M -62.47M -63.76M -428M -165M -2.05B -165M -162M -7.12B -4.27B -45.22M -39.65M -36.55M -34.21M -64.16M -65.49M -439M -170M -2.11B -170M -166M -7.31B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
26-06-29 202.68 +0.89% 1,420,979
26-06-25 ₹200.90 +3.65% 2,149,139
26-06-24 ₹193.83 +0.25% 1,328,781
26-06-23 ₹193.34 +2.36% 2,798,316
26-06-22 ₹188.88 +0.80% 2,421,801
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock